General information about company | |
Name of The Company | ROSSARI BIOTECH LIMITED |
BSE Scrip Code | 543213 |
NSE Symbol | ROSSARI |
MSE Symbol | NOTLISTED |
Date of Start of Financial Year | 01-04-2022 |
Date of End of Financial Year | 31-03-2023 |
Reporting Period | Second half yearly |
Date of Start of Reporting Period | 01-10-2022 |
Date of End of Reporting Period | 31-03-2023 |
Level of rounding to be used in disclosing related party transactions | Millions |
Whether the company has any related party? | Yes |
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? | Yes |
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public | NA | ||
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. | NA | ||
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)? | No | ||
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication? | |||
(b) If answer to above question is No, please explain the reason for not complying. |
Related party transactions | ||||||||||||||||||||||
Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken. | ||||||||||||||||||||||
Sr No. | Details of the party (listed entity /subsidiary) entering into the transaction | Details of the counterparty | Type of related party transaction | Details of other related party transaction | Value of the related party transaction as approved by the audit committee | Remarks on approval by audit committee | Value of transaction during the reporting period | In case monies are due to either party as a result of the transaction | In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments | Details of the loans, inter-corporate deposits, advances or investments | Notes | |||||||||||
Name | PAN | Name | PAN | Relationship of the counterparty with the listed entity or its subsidiary | Opening balance | Closing balance | Nature of indebtedness (loan/ issuance of debt/ any other etc.) | Details of other indebtedness | Cost | Tenure | Nature (loan/ advance/ intercorporate deposit/ investment ) | Interest Rate (%) | Tenure | Secured/ unsecured | Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) | |||||||
1 | Rossari Biotech Limited | Mr. Sunil Chari | Key Managerial Personnel | Remuneration | As per the Companies Act, 2013 and Shareholders' Approval | 5.808697 | 0 | 0 | Textual Information(1) | |||||||||||||
2 | Rossari Biotech Limited | Mr. Edward Menezes | Key Managerial Personnel | Remuneration | As per the Companies Act, 2013 and Shareholders' Approval | 5.803837 | 0 | 0 | Textual Information(2) | |||||||||||||
3 | Rossari Biotech Limited | Mr.Mikhail Menezes | Relative of Directors | Remuneration | As per the Companies Act, 2013 and Shareholders' Approval | 3.124455 | 0 | 0 | Textual Information(3) | |||||||||||||
4 | Rossari Biotech Limited | Mr.Yash Chari | Relative of Directors | Remuneration | As per the Companies Act, 2013 and Shareholders' Approval | 3.126254 | 0 | 0 | Textual Information(4) | |||||||||||||
5 | Rossari Biotech Limited | Mr. Ketan Sablok | Key Managerial Personnel | Remuneration | NA | 6.926609 | 0 | 0 | Textual Information(5) | |||||||||||||
6 | Rossari Biotech Limited | Ms. Manasi Nisal | Key Managerial Personnel | Remuneration | NA | 2.62371 | 0 | 0 | Textual Information(6) | |||||||||||||
7 | Rossari Biotech Limited | Ms. Parul Gupta | Key Managerial Personnel | Remuneration | NA | 0.85215 | 0 | 0 | Textual Information(7) | |||||||||||||
8 | Rossari Biotech Limited | Mr. Aseem Dhru | Independent Director | Any other transaction | Sitting Fees | NA | 0.7 | 0 | 0 | Textual Information(8) | ||||||||||||
9 | Rossari Biotech Limited | Mr.Robin Banerjee | Independent Director | Any other transaction | Sitting Fees | NA | 0.3 | 0 | 0 | Textual Information(9) | ||||||||||||
10 | Rossari Biotech Limited | Mr.Gautam Bhattacharya | Independent Director | Any other transaction | Sitting Fees | NA | 0.9 | 0 | 0 | Textual Information(10) | ||||||||||||
11 | Rossari Biotech Limited | Ms. Meher Castelino | Independent Director | Any other transaction | Sitting Fees | NA | 0.5 | 0 | 0 | Textual Information(11) | ||||||||||||
12 | Rossari Biotech Limited | Mr. Sharabh Pachory | Independent Director | Any other transaction | Sitting Fees | NA | 0.6 | 0 | 0 | Textual Information(12) | ||||||||||||
13 | Rossari Biotech Limited | Buzil Rossari Private Limited | Wholly Owned Subsidiary Company | Sale of goods or services | 450 | NA | 132.27686583 | 140.93966847 | 107.36957261 | Textual Information(13) | ||||||||||||
14 | Rossari Biotech Limited | Buzil Rossari Private Limited | Wholly Owned Subsidiary Company | Purchase of goods or services | 30 | NA | 0.308235 | 0 | 0 | Textual Information(14) | ||||||||||||
15 | Rossari Biotech Limited | Buzil Rossari Private Limited | Wholly Owned Subsidiary Company | Interest received | 250 | The Audit Committee has approved an aggregate limit of Rs.250 million | 0.613578 | 0.069041 | 0 | Textual Information(15) | ||||||||||||
16 | Rossari Biotech Limited | Buzil Rossari Private Limited | Wholly Owned Subsidiary Company | Loan | 250 | The Audit Committee has approved an aggregate limit of Rs.250 million | 20 | 20 | 0 | Textual Information(16) | ||||||||||||
17 | Rossari Biotech Limited | Buzil Rossari Private Limited | Wholly Owned Subsidiary Company | Any other transaction | Employee Cost - Recovery | 20 | The Audit Committee has approved an aggregate limit of Rs.20 million | 1.8095 | 0 | 0 | Textual Information(17) | |||||||||||
18 | Rossari Biotech Limited | Buzil Rossari Private Limited | Wholly Owned Subsidiary Company | Any other transaction | Employee Cost - Reimbursement | 20 | The Audit Committee has approved an aggregate limit of Rs.20 million | 0.49953 | 0 | 0 | Textual Information(18) | |||||||||||
19 | Rossari Biotech Limited | Rossari Consumer Products Private Limited | Wholly Owned Subsidiary Company | Sale of goods or services | 200 | NA | 5.11797916 | 3.06632151 | 9.10553751 | Textual Information(19) | ||||||||||||
20 | Rossari Biotech Limited | Rossari Consumer Products Private Limited | Wholly Owned Subsidiary Company | Any other transaction | Recovery of Expenses | 50 | NA | 0.196192 | 0 | 0.196192 | Textual Information(20) | |||||||||||
21 | Rossari Biotech Limited | Tristar Intermediates Private Limited | Subsidiary Company | Sale of goods or services | 150 | The Audit Committee has approved an aggregate limit of Rs.150 million | 0.07230815 | 19.52487048 | 4.17917114 | Textual Information(21) | ||||||||||||
22 | Rossari Biotech Limited | Tristar Intermediates Private Limited | Subsidiary Company | Any other transaction | Commission Income | 150 | The Audit Committee has approved an aggregate limit of Rs.150 million | 6.088753 | 0 | 0 | Textual Information(22) | |||||||||||
23 | Rossari Biotech Limited | Tristar Intermediates Private Limited | Subsidiary Company | Purchase of goods or services | 520 | NA | 351.37998 | 78.6450533435 | 317.03133256 | Textual Information(23) | ||||||||||||
24 | Rossari Biotech Limited | Tristar Intermediates Private Limited | Subsidiary Company | Any other transaction | Employee Cost - Recovery | 30 | The Audit Committee has approved an aggregate limit of Rs.30 million | 5.163169 | 0 | 0 | Textual Information(24) | |||||||||||
25 | Rossari Biotech Limited | Tristar Intermediates Private Limited | Subsidiary Company | Any other transaction | Recovery of Expenses | 30 | The Audit Committee has approved an aggregate limit of Rs.30 million | 0.525905 | 0 | 0 | Textual Information(25) | |||||||||||
26 | Rossari Biotech Limited | Unitop Chemicals Private Limited | Subsidiary Company | Sale of goods or services | 150 | The Audit Committee has approved an aggregate limit of Rs.150 million | 22.8515437 | 22.09736642 | 12.03813163 | Textual Information(26) | ||||||||||||
27 | Rossari Biotech Limited | Unitop Chemicals Private Limited | Subsidiary Company | Any other transaction | Commission Income | 150 | The Audit Committee has approved an aggregate limit of Rs.150 million | 7.512911 | 0 | 0 | Textual Information(27) | |||||||||||
28 | Rossari Biotech Limited | Unitop Chemicals Private Limited | Subsidiary Company | Purchase of goods or services | 1750 | NA | 472.09089384 | 124.28398341825 | 512.78090238 | Textual Information(28) | ||||||||||||
29 | Rossari Biotech Limited | Unitop Chemicals Private Limited | Subsidiary Company | Purchase of fixed assets | 50 | NA | 2.12813945 | 0 | 0 | Textual Information(29) | ||||||||||||
30 | Rossari Biotech Limited | Unitop Chemicals Private Limited | Subsidiary Company | Any other transaction | Employee Cost Recovery | 80 | The Audit Committee has approved an aggregate limit of Rs.80 million | 8.799702 | 0 | 0 | Textual Information(30) | |||||||||||
31 | Rossari Biotech Limited | Unitop Chemicals Private Limited | Subsidiary Company | Any other transaction | Recovery of Expenses | 80 | The Audit Committee has approved an aggregate limit of Rs.80 million | 2.62314847 | 0 | 0 | Textual Information(31) | |||||||||||
32 | Rossari Biotech Limited | Unitop Chemicals Private Limited | Subsidiary Company | Any other transaction | Investment in Equity Shares | Paid as per the terms of Share Purchase Agreement approved by the Board of Directors of the Company for acquisition of shares of Unitop Chemicals Private Limited from the existing shareholders. | 24 | 0 | 0 | Textual Information(32) | ||||||||||||
33 | Rossari Biotech Limited | Romakk Chemicals Private Limited | Associate | Sale of goods or services | 10 | NA | 0.620666 | 3.13379992 | 3.10144284 | Textual Information(33) | ||||||||||||
34 | Rossari Biotech Limited | Romakk Chemicals Private Limited | Associate | Purchase of goods or services | 400 | NA | 74.61013 | 63.6208955 | 38.86138724 | Textual Information(34) | ||||||||||||
35 | Rossari Biotech Limited | Romakk Chemicals Private Limited | Associate | Any other transaction | Employee Cost - Recovery | 10 | NA | 2.983828 | 0 | 0 | Textual Information(35) | |||||||||||
36 | Rossari Biotech Limited | K. K. Chempro (India) Pvt. Ltd | Related Party to Romakk Chemicals Private Limited (subsidiary company) | Any other transaction | Receivable Account | NA | 0 | 0.007453 | 0.007453 | Textual Information(36) | ||||||||||||
37 | Rossari Biotech Limited | K. K. Chempro (India) Pvt. Ltd | Related Party to Romakk Chemicals Private Limited (subsidiary company) | Purchase of goods or services | NA | 29.9336 | 16.554575 | 0.371385 | Textual Information(37) | |||||||||||||
38 | Rossari Biotech Limited | K K CHEMICAL INDUSTRIES | Related Party to Romakk Chemicals Private Limited (subsidiary company) | Any other transaction | Payable Account Debit Balance | NA | 0 | 0.045851 | 0.045851 | Textual Information(38) | ||||||||||||
39 | Rossari Biotech Limited | K K CHEMICAL INDUSTRIES | Related Party to Romakk Chemicals Private Limited (subsidiary company) | Any other transaction | Receivable Account Credit Balance | NA | 0 | 0.01155 | 0.01155 | Textual Information(39) | ||||||||||||
40 | Rossari Biotech Limited | McCoy Performance Silicones Pvt. Ltd. | Related Party to Romakk Chemicals Private Limited (subsidiary company) | Any other transaction | Payable Account Debit Balance | NA | 0 | 0.009249 | 0.009249 | Textual Information(40) | ||||||||||||
41 | Rossari Biotech Limited | McCoy Digital Private Limited | Related Party to Romakk Chemicals Private Limited (subsidiary company) | Any other transaction | Receivable Account Credit Balance | NA | 0 | 0.0251458 | 0.0251458 | Textual Information(41) | ||||||||||||
42 | Buzil Rossari Private Limited | Unitop Chemicals Private Limited | Fellow Subsidiary | Sale of goods or services | NA | 0.0215 | 0.34 | 0.35 | Textual Information(42) | |||||||||||||
43 | Buzil Rossari Private Limited | Unitop Chemicals Private Limited | Fellow Subsidiary | Any other transaction | Employee Cost - Recovery | 5 | NA | 0.589324 | 0 | 0 | Textual Information(43) | |||||||||||
44 | Buzil Rossari Private Limited | Tristar Intermediates Private Limited | Fellow Subsidiary | Sale of goods or services | NA | 0 | 0.374933 | 0.115901 | Textual Information(44) | |||||||||||||
45 | Buzil Rossari Private Limited | Tristar Intermediates Private Limited | Fellow Subsidiary | Any other transaction | Employee Cost - Recovery | NA | 0.196442 | 0 | 0 | Textual Information(45) | ||||||||||||
46 | Unitop Chemicals Private Limited | Gurudas Vishwas Aras | Independent Director | Any other transaction | Sitting Fees | NA | 0.1 | 0 | 0 | Textual Information(46) | ||||||||||||
47 | Unitop Chemicals Private Limited | Meher Castelino | Independent Director | Any other transaction | Sitting Fees | NA | 0.1 | 0 | 0 | Textual Information(47) | ||||||||||||
48 | Unitop Chemicals Private Limited | Tristar Intermediates Private Limited | Fellow Subsidiary | Sale of goods or services | 100 | NA | 39.25 | 2.59 | 37.48 | Textual Information(48) | ||||||||||||
49 | Unitop Chemicals Private Limited | Tristar Intermediates Private Limited | Fellow Subsidiary | Purchase of goods or services | 30 | NA | 4.74 | 0 | 5.44 | Textual Information(49) | ||||||||||||
50 | Unitop Chemicals Private Limited | Tristar Intermediates Private Limited | Fellow Subsidiary | Purchase of fixed assets | 10 | NA | 1.21 | 0 | 0 | Textual Information(50) | ||||||||||||
51 | Unitop Chemicals Private Limited | HEXTAR UNITOP SDN. BHD. | Joint Venture | Sale of goods or services | NA | 19.31 | 5.39 | 2.44 | Textual Information(51) | |||||||||||||
52 | Romakk Chemicals Pvt Ltd | Nitin Sethi | Key Managerial Personnel | Remuneration | NA | 1.714725018956 | 0 | 0 | Textual Information(52) | |||||||||||||
53 | Romakk Chemicals Pvt Ltd | Amit Malhotra | Key Managerial Personnel | Remuneration | NA | 0.6833 | 0 | 0 | Textual Information(53) | |||||||||||||
54 | Romakk Chemicals Pvt Ltd | Unitop Chemicals Private Limited | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Sale of goods or services | 50 | NA | 2.16 | 0 | 2.5488 | Textual Information(54) | ||||||||||||
55 | Romakk Chemicals Pvt Ltd | Unitop Chemicals Private Limited | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Purchase of goods or services | 50 | The Audit Committee has approved an aggregate limit of Rs.50 million | 1.3342 | 0 | 0.39648 | Textual Information(55) | ||||||||||||
56 | Romakk Chemicals Pvt Ltd | Tristar Intermediates Private Limited | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Purchase of goods or services | 50 | The Audit Committee has approved an aggregate limit of Rs.50 million | 2.335581 | 0 | 1.612116 | Textual Information(56) | ||||||||||||
57 | Romakk Chemicals Pvt Ltd | K K Chempro India Private Limited | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Purchase of goods or services | 50 | The Audit Committee has approved an aggregate limit of Rs.50 million | 10.9865 | 9.344577 | 4.27166587 | Textual Information(57) | ||||||||||||
58 | Romakk Chemicals Pvt Ltd | K K Chempro India Private Limited | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Any other transaction | Rent Paid | NA | 0.6 | 0.108 | 0.108 | Textual Information(58) | ||||||||||||
59 | Romakk Chemicals Pvt Ltd | Nitin Sethi (HUF) | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Any other transaction | Rent Paid | NA | 0.45 | 0 | 0.0675 | Textual Information(59) | ||||||||||||
60 | Romakk Chemicals Pvt Ltd | Sumant Agrawal (HUF) | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Any other transaction | Rent Paid | NA | 0.45 | 0 | 0.081 | Textual Information(60) | ||||||||||||
61 | Romakk Chemicals Pvt Ltd | Ms. Meher Castelino | Independent Director | Any other transaction | Sitting Fees | NA | 0.2 | 0 | 0 | Textual Information(61) | ||||||||||||
62 | Romakk Chemicals Pvt Ltd | Gurudas Vishwas Aras | Independent Director | Any other transaction | Sitting Fees | NA | 0.2 | 0 | 0 | Textual Information(62) | ||||||||||||
63 | Tristar Intermediates Pvt Ltd | Ms. Meher Castelino | Independent Director | Any other transaction | Sitting Fees | NA | 0.275 | 0 | 0 | Textual Information(63) | ||||||||||||
64 | Tristar Intermediates Pvt Ltd | Gurudas Vishwas Aras | Independent Director | Any other transaction | Sitting Fees | NA | 0.3 | 0 | 0 | Textual Information(64) | ||||||||||||
Total value of transaction during the reporting period | 1290.67884161896 |
Text Block | ||
Textual Information(1) | ||
Textual Information(2) | ||
Textual Information(3) | ||
Textual Information(4) | ||
Textual Information(5) | ||
Textual Information(6) | ||
Textual Information(7) | ||
Textual Information(8) | ||
Textual Information(9) | ||
Textual Information(10) | ||
Textual Information(11) | ||
Textual Information(12) | ||
Textual Information(13) | ||
Textual Information(14) | ||
Textual Information(15) | The Audit Committee has approved an aggregate limit of Rs.250 million | |
Textual Information(16) | The Audit Committee has approved an aggregate limit of Rs.250 million | |
Textual Information(17) | The Audit Committee has approved an aggregate limit of Rs.20 million | |
Textual Information(18) | The Audit Committee has approved an aggregate limit of Rs.20 million | |
Textual Information(19) | ||
Textual Information(20) | ||
Textual Information(21) | The Audit Committee has approved an aggregate limit of Rs.150 million | |
Textual Information(22) | The Audit Committee has approved an aggregate limit of Rs.150 million | |
Textual Information(23) | ||
Textual Information(24) | The Audit Committee has approved an aggregate limit of Rs.30 million | |
Textual Information(25) | The Audit Committee has approved an aggregate limit of Rs.30 million | |
Textual Information(26) | The Audit Committee has approved an aggregate limit of Rs.150 million | |
Textual Information(27) | The Audit Committee has approved an aggregate limit of Rs.150 million | |
Textual Information(28) | ||
Textual Information(29) | ||
Textual Information(30) | The Audit Committee has approved an aggregate limit of Rs.80 million | |
Textual Information(31) | The Audit Committee has approved an aggregate limit of Rs.80 million | |
Textual Information(32) | ||
Textual Information(33) | ||
Textual Information(34) | ||
Textual Information(35) | ||
Textual Information(36) | ||
Textual Information(37) | ||
Textual Information(38) | ||
Textual Information(39) | ||
Textual Information(40) | ||
Textual Information(41) | ||
Textual Information(42) | ||
Textual Information(43) | ||
Textual Information(44) | ||
Textual Information(45) | ||
Textual Information(46) | ||
Textual Information(47) | ||
Textual Information(48) | ||
Textual Information(49) | ||
Textual Information(50) | ||
Textual Information(51) | ||
Textual Information(52) | ||
Textual Information(53) | ||
Textual Information(54) | ||
Textual Information(55) | The Audit Committee has approved an aggregate limit of Rs.50 million | |
Textual Information(56) | The Audit Committee has approved an aggregate limit of Rs.50 million | |
Textual Information(57) | The Audit Committee has approved an aggregate limit of Rs.50 million | |
Textual Information(58) | ||
Textual Information(59) | ||
Textual Information(60) | ||
Textual Information(61) | ||
Textual Information(62) | ||
Textual Information(63) | ||
Textual Information(64) | Notes: 1. Dividend paid by Rossari Biotech Limited ("the Company") to related parties is not included in statement above since payment of dividend by a listed company is not a related party transaction as per Regulation 2(1 )(zc) of the SEBI LODR Regulations. 2. The value of the related party transaction approved by the audit committee represents the value approved by audit committee of the Company. 3. Remuneration does not include stock options granted in accordance with the Rossari Employee Stock Option Plan- 2019, these options would vest after fulfillment of vesting conditions in accordance with the plan. Remuneration reported pertains to the amount paid during the period. 4. Transactions between members of the Group (between Rossari Biotech Limited and its subsidiary or between subsidiaries) are reported once. 5. Paid as per the terms of Share Purchase Agreement approved by the Board of Directors of the Company for acquisition of shares of Unitop Chemicals Private Limited from the existing shareholders. |